These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions. Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M. Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554 [Abstract] [Full Text] [Related]
3. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M. Neuropsychopharmacology; 2006 Jan 15; 31(1):212-20. PubMed ID: 16123748 [Abstract] [Full Text] [Related]
5. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients. Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F. Psychoneuroendocrinology; 2009 Jan 15; 34(1):99-109. PubMed ID: 18829172 [Abstract] [Full Text] [Related]
9. Hypothalamic--pituitary--adrenal axis and monoamine transmitter activity in depression: a pilot study of central and peripheral effects of electroconvulsive therapy. Rudorfer MV, Risby ED, Osman OT, Gold PW, Potter WZ. Biol Psychiatry; 1991 Feb 01; 29(3):253-64. PubMed ID: 1707686 [Abstract] [Full Text] [Related]
10. The influence of Hatha yoga as an add-on treatment in major depression on hypothalamic-pituitary-adrenal-axis activity: a randomized trial. Sarubin N, Nothdurfter C, Schüle C, Lieb M, Uhr M, Born C, Zimmermannc R, Bühner M, Konopka K, Rupprecht R, Baghai TC. J Psychiatr Res; 2014 Jun 01; 53():76-83. PubMed ID: 24655586 [Abstract] [Full Text] [Related]
11. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression. Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K. Psychoneuroendocrinology; 2008 Feb 01; 33(2):152-61. PubMed ID: 18068306 [Abstract] [Full Text] [Related]
17. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression. Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E. Psychoneuroendocrinology; 2004 Oct 01; 29(9):1101-8. PubMed ID: 15219633 [Abstract] [Full Text] [Related]
18. Dissociation between ACTH and cortisol response in DEX-CRH test in patients with panic disorder. Petrowski K, Wintermann GB, Kirschbaum C, Bornstein SR. Psychoneuroendocrinology; 2012 Aug 01; 37(8):1199-208. PubMed ID: 22277728 [Abstract] [Full Text] [Related]
20. The dex/CRH test--is it better than the DST? Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH. Psychoneuroendocrinology; 2006 Aug 01; 31(7):889-94. PubMed ID: 16701957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]